<?xml version="1.0" encoding="UTF-8"?>

<wo-patent-document lang="fr" status="175" country="OA">
  <wo-bibliographic-data status="BR100 Migrated">
    <classifications-ipcr>
      <classification-ipcr sequence="0001">
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>31</main-group>
        <subgroup>166</subgroup>
        <classification-value>A</classification-value>
      </classification-ipcr>
      <classification-ipcr sequence="0002">
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>47</main-group>
        <subgroup>10</subgroup>
        <classification-value>A</classification-value>
      </classification-ipcr>
      <classification-ipcr sequence="0003">
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>47</main-group>
        <subgroup>26</subgroup>
        <classification-value>A</classification-value>
      </classification-ipcr>
      <classification-ipcr sequence="0004">
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>9</main-group>
        <subgroup>48</subgroup>
        <classification-value>A</classification-value>
      </classification-ipcr>
      <classification-ipcr sequence="0005">
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <section>A</section>
        <class>61</class>
        <subclass>P</subclass>
        <main-group>35</main-group>
        <subgroup>00</subgroup>
        <classification-value>A</classification-value>
      </classification-ipcr>
    </classifications-ipcr>
    <application-reference>
      <document-id>
        <country>OA</country>
        <doc-number>1/2009/000234</doc-number>
        <date>20080116</date>
      </document-id>
    </application-reference>
    <priority-claims>
      <priority-claim sequence="0001" kind="national">
        <country>US</country>
        <doc-number>60/880,755</doc-number>
        <date>20070116</date>
      </priority-claim>
    </priority-claims>
    <parties>
      <applicants>
        <applicant sequence="0001" app-type="applicant" designation="all">
          <addressbook lang="fr">
            <name>BIPAR SCIENCES, INC.</name>
            <address>
              <address-1>400 Oyster Point Boulevard, Suite 200</address-1>
              <country>US</country>
            </address>
          </addressbook>
          <nationality>
            <country/>
          </nationality>
          <residence>
            <country>US</country>
          </residence>
        </applicant>
      </applicants>
      <inventors>
        <inventor sequence="0001">
          <addressbook lang="fr">
            <name>LI, Lingyun</name>
            <address>
              <address-1>945 Flying Fish Street</address-1>
              <country>US</country>
            </address>
          </addressbook>
        </inventor>
        <inventor sequence="0002">
          <addressbook lang="fr">
            <name>OSSOVSKAYA, Valeria</name>
            <address>
              <address-1>338 Spear Street, Unit 14C</address-1>
              <country>US</country>
            </address>
          </addressbook>
        </inventor>
        <inventor sequence="0003">
          <addressbook lang="fr">
            <name>SHERMAN, Barry</name>
            <address>
              <address-1>2830 Churchill Drive</address-1>
              <country>US</country>
            </address>
          </addressbook>
        </inventor>
      </inventors>
      <agents>
        <agent sequence="0001" rep-type="agent">
          <addressbook lang="fr">
            <name>SCP NICO HALLE &amp; Co. LAW FIRM</name>
            <address>
              <address-1>ADRESSE A COMPLETER</address-1>
              <country>CM</country>
            </address>
          </addressbook>
        </agent>
      </agents>
    </parties>
    <invention-title lang="fr">Formulations for cancer treatment.</invention-title>
    <wo-term-of-grant>
      <date>20130329</date>
      <doc-number>015854</doc-number>
    </wo-term-of-grant>
    <wo-date-of-expiry>20280116</wo-date-of-expiry>
    <pct-or-regional-filing-data>
      <document-id>
        <country>US</country>
        <doc-number>PCT/US08/051214</doc-number>
        <date>20080116</date>
      </document-id>
    </pct-or-regional-filing-data>
    <pct-or-regional-publishing-data>
      <document-id>
        <country>IB</country>
        <doc-number>WO/08/089272</doc-number>
        <date>20080724</date>
      </document-id>
    </pct-or-regional-publishing-data>
    <wo-national-office-event national-office-event-type="Filed" doc-number="OA/1/2009/000234" event-name="Filing">
      <wo-national-office-event-date>
        <date>20080116</date>
      </wo-national-office-event-date>
    </wo-national-office-event>
    <wo-national-office-event national-office-event-type="175" event-name="-">
      <wo-national-office-event-date>
        <date>20090715</date>
      </wo-national-office-event-date>
    </wo-national-office-event>
    <wo-national-office-event national-office-event-type="Registered" doc-number="015854" event-name="Registration">
      <wo-national-office-event-date>
        <date>20130329</date>
      </wo-national-office-event-date>
    </wo-national-office-event>
    <wo-national-office-filing-data appl-type="BR Brevet" file-type="1">
      <kind-of-protection>BR Brevet PCT</kind-of-protection>
    </wo-national-office-filing-data>
  </wo-bibliographic-data>
  <abstract lang="fr">
    <p num="0001">The present invention provides compositions of matter, kits, and methods for use in treating cancer and viral conditions. In particular the invention provides for pharmaceutical compositions containing nitrobenzamide compounds that have enhanced solubility in aqueous solutions.</p>
  </abstract>
</wo-patent-document>
